| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5671776 | Clinical Microbiology and Infection | 2017 | 41 Pages |
Abstract
In patients with CHB, measurement of I97L and additional mutation P79Q would be useful for predicting persistent low HBV DNA, normal ALT, and HBsAg clearance.
Related Topics
Life Sciences
Immunology and Microbiology
Microbiology
Authors
T. Honda, M. Ishigami, Y. Ishizu, T. Kuzuya, K. Hayashi, T. Ishikawa, Y. Murakami, M. Iwadate, H. Umeyama, H. Toyoda, T. Kumada, Y. Katano, H. Goto, Y. Hirooka,